| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Schiff Andrew N is a Director at Aclaris Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 12 sells.
Estimated insider holdings value: $63K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2022 | ACRS Aclaris Therapeutics, Inc. | Director | Sell | 53,926 | $17.05 | $919,589.25 | -3.8% | -22.4% | -96.1% | |
| Oct 26, 2022 | ACRS Aclaris Therapeutics, Inc. | Director | Sell | 41,174 | $17.01 | $700,355.02 | -2.7% | -0.5% | -72.2% | |
| Oct 18, 2022 | ACRS Aclaris Therapeutics, Inc. | Director | Sell | 52,037 | $16.57 | $862,109.13 | -4.6% | +5.3% | -68.9% | |
| Oct 7, 2022 | ACRS Aclaris Therapeutics, Inc. | Director | Sell | 7,324 | $16.16 | $118,349.25 | -1.2% | -3.7% | -61.7% | |
| Oct 6, 2022 | ACRS Aclaris Therapeutics, Inc. | Director | Sell | 45,539 | $16.45 | $749,002.06 | -3.6% | -10.4% | -63.7% | |
| Jun 17, 2022 | ACRS Aclaris Therapeutics, Inc. | Director | Sell | 19,565 | $15.14 | $296,268.88 | -100% | -7.8% | -34.5% | |
| Aug 16, 2017 | ACRS Aclaris Therapeutics, Inc. | Director | Buy | 108,601 | $23.02 | $2,499,995.02 | +20.7% | - | - |